VHT Vanguard Health Care ETF
326.27
-2.74 (-0.83%)
Koers per Aug 26, 2026 20:00 UTC · Market data delayed approximately 15–20 minutes unless otherwise indicated.
| Vorige slotkoers | 329.01 | Dagbandbreedte | 325.83 – 328.09 |
| 52-weeksbereik | 249.57 – 330.75 | Volume | 279.58K |
| Gem. volume | 238.32K | AUM | $20.90B (Aug 27, 2026) |
| Kostenratio | 0.09% | Yield (TTM) | 1.45% |
| NAV | 326.13 | Premie/korting | +0.04% indicatief |
| Oprichtingsdatum | Jan 26, 2004 | Posities | 411 |
| Uitgevende instelling | Vanguard | Beurs | AMEX |
| Categorie | Healthcare | Gevolgde index | Niet vermeld in brondata |
| CUSIP | 92204A504 | ISIN | US92204A5048 |
| Beheer | Niet vermeld in brondata | ||
Over deze ETF
This exchange-traded fund endeavors to replicate the financial outcomes of a designated benchmark index, which assesses the investment appreciation of equities within the healthcare sector. It operates under a passive management style, generally utilizing a full replication strategy; however, a sampling approach may be adopted when necessitated by regulatory requirements. The fund's portfolio is comprised of shares from enterprises engaged in providing medical or health-related goods, services, technological innovations, or equipment.
Beschrijving van de fondsgegevensprovider · profiel per Aug 27, 2026.
Koersgrafiek
Dagelijkse slotkoersen (koersrendement, niet totaalrendement). Vergelijkingslijnen zijn genormaliseerd naar procentuele verandering vanaf het begin van de periode. Bron: Financial Modeling Prep.
Rendement
| 1M | 3M | 6M | YTD | 1Y | 3Y* | 5Y* | 10Y* | Oprichting* | |
|---|---|---|---|---|---|---|---|---|---|
| Koersrendement | +6.39% | +17.41% | +11.78% | +13.35% | +28.30% | +10.12% | +4.57% | +9.33% | +8.66% |
| Totaalrendement | +6.39% | +17.82% | +12.58% | +14.16% | +30.51% | +11.83% | +6.13% | +10.96% | +10.20% |
* Geannualiseerd. Totaalrendement gebruikt de dividendgecorrigeerde prijsreeks (herbelegde uitkeringen); prijsrendement gebruikt niet-gecorrigeerde slotkoersen. Rendement t/m Aug 26, 2026. Resultaten uit het verleden bieden geen garantie voor de toekomst.
Kosten
| Netto kostenratio | 0.09% | Jaarlijkse kosten van een investering van $10.000 | $9.00 |
Uitsluitend ter illustratie: kostenratio × $10.000. Handelskosten, bid/ask-spreads, belastingen en wijzigingen in beleggingswaarde zijn niet inbegrepen. Details over bruto- en nettokostenratio's en eventuele kostenvergoedingen staan in het prospectus.
Posities
Posities per Aug 26, 2026 — rapportagedatum van de portefeuille van de dataprovider; holdings zijn geen live posities. 421 rijen in database.
| # | Positie | Ticker | Gewicht | Aandelen | Marktwaarde |
|---|---|---|---|---|---|
| 1 | Eli Lilly & Co | LLY | 13.40% | 2.44M | $2.80B |
| 2 | Johnson & Johnson | JNJ | 8.84% | 7.22M | $1.85B |
| 3 | AbbVie Inc | ABBV | 6.45% | 5.37M | $1.35B |
| 4 | UnitedHealth Group Inc | UNH | 5.46% | 2.76M | $1.14B |
| 5 | Merck & Co Inc | MRK | 4.67% | 7.51M | $978.1M |
| 6 | Thermo Fisher Scientific Inc | TMO | 3.10% | 1.13M | $648.5M |
| 7 | Amgen Inc | AMGN | 3.01% | 1.64M | $630.8M |
| 8 | Abbott Laboratories | ABT | 2.67% | 5.29M | $559.3M |
| 9 | Gilead Sciences Inc | GILD | 2.35% | 3.77M | $491.1M |
| 10 | Pfizer Inc | PFE | 2.07% | 17.28M | $432.3M |
| 11 | Bristol-Myers Squibb Co | BMY | 1.94% | 6.20M | $405.2M |
| 12 | CVS Health Corp | CVS | 1.93% | 3.87M | $403.7M |
| 13 | Intuitive Surgical Inc | ISRG | 1.82% | 1.08M | $381.3M |
| 14 | Danaher Corp | DHR | 1.80% | 1.94M | $377.3M |
| 15 | Vertex Pharmaceuticals Inc | VRTX | 1.76% | 772.90K | $368.8M |
| 16 | Stryker Corp | SYK | 1.63% | 1.05M | $341.1M |
| 17 | Medtronic PLC | MDT | 1.59% | 3.90M | $333.1M |
| 18 | McKesson Corp | MCK | 1.52% | 372.15K | $318.6M |
| 19 | Elevance Health Inc | ELV | 1.17% | 653.10K | $245.5M |
| 20 | Regeneron Pharmaceuticals Inc | REGN | 1.15% | 315.73K | $240.8M |
| 21 | Cigna Group/The | CI | 1.07% | 801.18K | $223.6M |
| 22 | Boston Scientific Corp | BSX | 1.01% | 4.52M | $211.0M |
| 23 | HCA Healthcare Inc | HCA | 0.91% | 475.53K | $191.4M |
| 24 | Cencora Inc | COR | 0.84% | 561.46K | $174.8M |
| 25 | Cardinal Health Inc | CAH | 0.79% | 714.92K | $164.5M |
| 26 | Edwards Lifesciences Corp | EW | 0.72% | 1.75M | $150.8M |
| 27 | Becton Dickinson & Co | BDX | 0.69% | 865.97K | $143.4M |
| 28 | IDEXX Laboratories Inc | IDXX | 0.64% | 241.35K | $134.9M |
| 29 | Humana Inc | HUM | 0.63% | 364.85K | $132.8M |
| 30 | IQVIA Holdings Inc | IQV | 0.58% | 515.50K | $121.2M |
| 31 | Agilent Technologies Inc | A | 0.57% | 858.72K | $118.8M |
| 32 | Waters Corp | WAT | 0.54% | 298.87K | $112.8M |
| 33 | Natera Inc | NTRA | 0.52% | 409.07K | $109.5M |
| 34 | Zoetis Inc | ZTS | 0.47% | 1.28M | $98.8M |
| 35 | Dexcom Inc | DXCM | 0.47% | 1.17M | $97.6M |
| 36 | GE HealthCare Technologies Inc | GEHC | 0.45% | 1.39M | $94.3M |
| 37 | ResMed Inc | RMD | 0.45% | 442.71K | $93.4M |
| 38 | Centene Corp | CNC | 0.44% | 1.49M | $93.0M |
| 39 | Illumina Inc | ILMN | 0.44% | 452.84K | $92.9M |
| 40 | Revolution Medicines Inc | RVMD | 0.44% | 491.48K | $92.2M |
| 41 | Veeva Systems Inc | VEEV | 0.44% | 446.70K | $91.0M |
| 42 | Biogen Inc | BIIB | 0.43% | 445.82K | $90.5M |
| 43 | Mettler-Toledo International Inc | MTD | 0.42% | 61.76K | $87.5M |
| 44 | Alnylam Pharmaceuticals Inc | ALNY | 0.40% | 403.02K | $82.8M |
| 45 | Quest Diagnostics Inc | DGX | 0.37% | 333.76K | $77.8M |
| 46 | Labcorp Holdings Inc | LH | 0.37% | 250.30K | $77.4M |
| 47 | West Pharmaceutical Services Inc | WST | 0.36% | 218.87K | $74.6M |
| 48 | STERIS PLC | STE | 0.33% | 297.99K | $68.1M |
| 49 | Tenet Healthcare Corp | THC | 0.32% | 264.37K | $67.4M |
| 50 | Insmed Inc | INSM | 0.30% | 639.45K | $63.1M |
| 51 | Viatris Inc | VTRS | 0.30% | 3.54M | $62.2M |
| 52 | United Therapeutics Corp | UTHR | 0.30% | 119.88K | $62.1M |
| 53 | Incyte Corp | INCY | 0.29% | 514.08K | $61.4M |
| 54 | Guardant Health Inc | GH | 0.29% | 368.84K | $59.7M |
| 55 | Zimmer Biomet Holdings Inc | ZBH | 0.26% | 587.87K | $55.2M |
| 56 | Neurocrine Biosciences Inc | NBIX | 0.23% | 289.68K | $48.3M |
| 57 | Roivant Sciences Ltd | ROIV | 0.23% | 1.42M | $48.0M |
| 58 | Moderna Inc | MRNA | 0.23% | 874.90K | $48.0M |
| 59 | Medline Inc | MDLN | 0.21% | 1.12M | $44.1M |
| 60 | Cooper Cos Inc/The | COO | 0.20% | 593.01K | $42.9M |
| 61 | Jazz Pharmaceuticals PLC | JAZZ | 0.20% | 168.38K | $42.6M |
| 62 | Baxter International Inc | BAX | 0.20% | 1.57M | $41.1M |
| 63 | Medpace Holdings Inc | MEDP | 0.19% | 69.44K | $40.1M |
| 64 | Elanco Animal Health Inc | ELAN | 0.19% | 1.52M | $40.1M |
| 65 | Revvity Inc | RVTY | 0.18% | 340.09K | $38.3M |
| 66 | Solventum Corp | SOLV | 0.18% | 447.53K | $38.2M |
| 67 | Exelixis Inc | EXEL | 0.18% | 714.15K | $37.9M |
| 68 | Penumbra Inc | PEN | 0.17% | 113.44K | $36.4M |
| 69 | Bridgebio Pharma Inc | BBIO | 0.17% | 446.46K | $35.8M |
| 70 | Align Technology Inc | ALGN | 0.17% | 207.01K | $35.0M |
| 71 | Charles River Laboratories International Inc | CRL | 0.17% | 149.86K | $34.8M |
| 72 | Insulet Corp | PODD | 0.17% | 210.63K | $34.8M |
| 73 | Bio-Techne Corp | TECH | 0.16% | 475.99K | $34.3M |
| 74 | Encompass Health Corp | EHC | 0.16% | 302.09K | $33.6M |
| 75 | Corcept Therapeutics Inc | CORT | 0.16% | 290.86K | $33.3M |
| 76 | BioMarin Pharmaceutical Inc | BMRN | 0.15% | 540.11K | $32.4M |
| 77 | Molina Healthcare Inc | MOH | 0.15% | 158.41K | $31.0M |
| 78 | Ensign Group Inc/The | ENSG | 0.15% | 172.98K | $30.8M |
| 79 | Arrowhead Pharmaceuticals Inc | ARWR | 0.15% | 361.43K | $30.6M |
| 80 | Halozyme Therapeutics Inc | HALO | 0.14% | 360.20K | $29.7M |
| 81 | Glaukos Corp | GKOS | 0.13% | 167.54K | $27.9M |
| 82 | Avantor Inc | AVTR | 0.13% | 2.01M | $27.6M |
| 83 | Globus Medical Inc | GMED | 0.13% | 342.12K | $27.0M |
| 84 | BrightSpring Health Services Inc | BTSG | 0.13% | 440.81K | $26.3M |
| 85 | Axsome Therapeutics Inc | AXSM | 0.13% | 120.65K | $26.3M |
| 86 | Universal Health Services Inc | UHS | 0.12% | 155.11K | $26.1M |
| 87 | Cytokinetics Inc | CYTK | 0.12% | 337.39K | $26.0M |
| 88 | HealthEquity Inc | HQY | 0.12% | 256.93K | $25.8M |
| 89 | Henry Schein Inc | HSIC | 0.12% | 296.54K | $25.4M |
| 90 | Ionis Pharmaceuticals Inc | IONS | 0.12% | 476.49K | $24.7M |
| 91 | SLBBH1142 | — | 0.12% | 245.90K | $24.6M |
| 92 | DaVita Inc | DVA | 0.12% | 101.50K | $24.4M |
| 93 | Alkermes PLC | ALKS | 0.11% | 479.83K | $23.5M |
| 94 | TG Therapeutics Inc | TGTX | 0.11% | 448.54K | $23.3M |
| 95 | Crinetics Pharmaceuticals Inc | CRNX | 0.11% | 278.91K | $23.3M |
| 96 | Repligen Corp | RGEN | 0.11% | 158.73K | $22.4M |
| 97 | Praxis Precision Medicines Inc | PRAX | 0.10% | 69.81K | $21.5M |
| 98 | Krystal Biotech Inc | KRYS | 0.10% | 62.61K | $21.4M |
| 99 | Protagonist Therapeutics Inc | PTGX | 0.10% | 155.12K | $21.2M |
| 100 | Madrigal Pharmaceuticals Inc | MDGL | 0.10% | 45.29K | $21.2M |
| 101 | Chemed Corp | CHE | 0.10% | 39.75K | $21.2M |
| 102 | Bruker Corp | BRKR | 0.10% | 323.64K | $20.3M |
| 103 | Vaxcyte Inc | PCVX | 0.10% | 371.44K | $20.1M |
| 104 | Lantheus Holdings Inc | LNTH | 0.09% | 197.70K | $19.7M |
| 105 | Teleflex Inc | TFX | 0.09% | 134.28K | $18.4M |
| 106 | Bio-Rad Laboratories Inc | BIO | 0.09% | 55.00K | $17.9M |
| 107 | Ligand Pharmaceuticals Inc | LGND | 0.08% | 59.04K | $17.0M |
| 108 | Spyre Therapeutics Inc | SYRE | 0.08% | 170.25K | $16.7M |
| 109 | Hims & Hers Health Inc | HIMS | 0.08% | 600.71K | $16.7M |
| 110 | Rhythm Pharmaceuticals Inc | RYTM | 0.08% | 166.42K | $16.5M |
| 111 | Liquidia Corp | LQDA | 0.08% | 194.16K | $16.3M |
| 112 | Twist Bioscience Corp | TWST | 0.08% | 172.79K | $15.8M |
| 113 | Apogee Therapeutics Inc | APGE | 0.07% | 116.10K | $15.6M |
| 114 | Merit Medical Systems Inc | MMSI | 0.07% | 181.56K | $15.4M |
| 115 | 10X Genomics Inc | TXG | 0.07% | 321.88K | $15.2M |
| 116 | Sotera Health Co | SHC | 0.07% | 845.93K | $15.1M |
| 117 | Definium Therapeutics Inc | DFTX | 0.07% | 334.89K | $14.6M |
| 118 | Cogent Biosciences Inc | COGT | 0.07% | 374.16K | $14.6M |
| 119 | PTC Therapeutics Inc | PTCT | 0.07% | 214.09K | $14.6M |
| 120 | Kymera Therapeutics Inc | KYMR | 0.07% | 136.85K | $14.2M |
| 121 | Travere Therapeutics Inc | TVTX | 0.07% | 252.21K | $14.1M |
| 122 | Tempus AI Inc | TEM | 0.07% | 317.65K | $13.9M |
| 123 | Mirum Pharmaceuticals Inc | MIRM | 0.07% | 128.73K | $13.6M |
| 124 | Envista Holdings Corp | NVST | 0.07% | 498.27K | $13.6M |
| 125 | MKTLIQ 12/31/2049 | — | 0.06% | 13.44M | $13.4M |
| 126 | LivaNova PLC | LIVN | 0.06% | 166.34K | $13.3M |
| 127 | RadNet Inc | RDNT | 0.06% | 201.11K | $12.8M |
| 128 | Integer Holdings Corp | ITGR | 0.06% | 104.83K | $12.7M |
| 129 | Indivior Pharmaceuticals Inc | INDV | 0.06% | 315.06K | $12.6M |
| 130 | ICU Medical Inc | ICUI | 0.06% | 72.42K | $12.2M |
| 131 | Haemonetics Corp | HAE | 0.06% | 141.54K | $12.1M |
| 132 | Dianthus Therapeutics Inc | DNTH | 0.06% | 111.98K | $12.0M |
| 133 | IRhythm Holdings Inc | IRTC | 0.06% | 98.33K | $11.5M |
| 134 | Veracyte Inc | VCYT | 0.05% | 241.07K | $11.2M |
| 135 | Concentra Group Holdings Parent Inc | CON | 0.05% | 352.20K | $11.1M |
| 136 | CG oncology Inc | CGON | 0.05% | 154.53K | $11.0M |
| 137 | Option Care Health Inc | OPCH | 0.05% | 474.45K | $10.9M |
| 138 | Scholar Rock Holding Corp | SRRK | 0.05% | 227.54K | $10.8M |
| 139 | Organon & Co | OGN | 0.05% | 789.73K | $10.7M |
| 140 | Viking Therapeutics Inc | VKTX | 0.05% | 334.59K | $10.6M |
| 141 | Dyne Therapeutics Inc | DYN | 0.05% | 417.92K | $10.5M |
| 142 | Erasca Inc | ERAS | 0.05% | 545.11K | $9.9M |
| 143 | Brookdale Senior Living Inc | BKD | 0.05% | 649.01K | $9.5M |
| 144 | Denali Therapeutics Inc | DNLI | 0.04% | 408.93K | $9.4M |
| 145 | Oruka Therapeutics Inc | ORKA | 0.04% | 95.27K | $9.2M |
| 146 | Arcutis Biotherapeutics Inc | ARQT | 0.04% | 338.50K | $9.1M |
| 147 | ACADIA Pharmaceuticals Inc | ACAD | 0.04% | 349.00K | $9.0M |
| 148 | Amneal Pharmaceuticals Inc | AMRX | 0.04% | 483.77K | $8.9M |
| 149 | Alignment Healthcare Inc | ALHC | 0.04% | 590.30K | $8.8M |
| 150 | Hinge Health Inc | HNGE | 0.04% | 115.98K | $8.7M |
| 151 | Ideaya Biosciences Inc | IDYA | 0.04% | 241.66K | $8.6M |
| 152 | National HealthCare Corp | NHC | 0.04% | 37.71K | $8.5M |
| 153 | Kiniksa Pharmaceuticals International Plc | KNSA | 0.04% | 111.34K | $8.3M |
| 154 | DENTSPLY SIRONA Inc | XRAY | 0.04% | 610.92K | $8.2M |
| 155 | Adaptive Biotechnologies Corp | ADPT | 0.04% | 349.82K | $7.9M |
| 156 | GRAIL Inc | GRAL | 0.04% | 115.07K | $7.9M |
| 157 | Celldex Therapeutics Inc | CLDX | 0.04% | 206.59K | $7.9M |
| 158 | Enliven Therapeutics Inc | ELVN | 0.04% | 143.06K | $7.8M |
| 159 | ImmunityBio Inc | IBRX | 0.04% | 1.09M | $7.8M |
| 160 | Immunovant Inc | IMVT | 0.04% | 200.68K | $7.8M |
| 161 | Tango Therapeutics Inc | TNGX | 0.04% | 283.44K | $7.7M |
| 162 | Doximity Inc | DOCS | 0.04% | 365.69K | $7.6M |
| 163 | TransMedics Group Inc | TMDX | 0.04% | 98.80K | $7.6M |
| 164 | Neogen Corp | NEOG | 0.04% | 627.24K | $7.6M |
| 165 | Arcus Biosciences Inc | RCUS | 0.04% | 266.15K | $7.5M |
| 166 | Waystar Holding Corp | WAY | 0.04% | 350.81K | $7.4M |
| 167 | Supernus Pharmaceuticals Inc | SUPN | 0.04% | 165.88K | $7.4M |
| 168 | Prestige Consumer Healthcare Inc | PBH | 0.03% | 143.50K | $7.2M |
| 169 | Vericel Corp | VCEL | 0.03% | 155.52K | $7.1M |
| 170 | Acadia Healthcare Co Inc | ACHC | 0.03% | 237.28K | $7.0M |
| 171 | Privia Health Group Inc | PRVA | 0.03% | 295.24K | $7.0M |
| 172 | Beam Therapeutics Inc | BEAM | 0.03% | 270.30K | $6.9M |
| 173 | Progyny Inc | PGNY | 0.03% | 219.74K | $6.8M |
| 174 | Relay Therapeutics Inc | RLAY | 0.03% | 357.81K | $6.7M |
| 175 | Pediatrix Medical Group Inc | MD | 0.03% | 251.91K | $6.7M |
| 176 | Nektar Therapeutics | NKTR | 0.03% | 93.05K | $6.6M |
| 177 | Addus HomeCare Corp | ADUS | 0.03% | 55.13K | $6.4M |
| 178 | Ultragenyx Pharmaceutical Inc | RARE | 0.03% | 253.50K | $6.3M |
| 179 | Axogen Inc | AXGN | 0.03% | 149.47K | $6.3M |
| 180 | LeMaitre Vascular Inc | LMAT | 0.03% | 62.15K | $6.3M |
| 181 | Immunome Inc | IMNM | 0.03% | 274.52K | $6.2M |
| 182 | uniQure NV | QURE | 0.03% | 142.19K | $6.2M |
| 183 | NeoGenomics Inc | NEO | 0.03% | 393.67K | $6.0M |
| 184 | Alumis Inc | ALMS | 0.03% | 205.41K | $5.8M |
| 185 | Disc Medicine Inc | IRON | 0.03% | 75.25K | $5.8M |
| 186 | CareDx Inc | CDNA | 0.03% | 132.04K | $5.8M |
| 187 | ADMA Biologics Inc | ADMA | 0.03% | 669.31K | $5.7M |
| 188 | UFP Technologies Inc | UFPT | 0.03% | 22.19K | $5.7M |
| 189 | BioCryst Pharmaceuticals Inc | BCRX | 0.03% | 629.21K | $5.7M |
| 190 | Edgewise Therapeutics Inc | EWTX | 0.03% | 146.41K | $5.6M |
| 191 | LifeStance Health Group Inc | LFST | 0.03% | 531.12K | $5.6M |
| 192 | AtriCure Inc | ATRC | 0.03% | 145.86K | $5.5M |
| 193 | PACS Group Inc | PACS | 0.03% | 119.13K | $5.5M |
| 194 | SELLAS Life Sciences Group Inc | SLS | 0.03% | 544.41K | $5.4M |
| 195 | Fortrea Holdings Inc | FTRE | 0.03% | 278.37K | $5.3M |
| 196 | Tarsus Pharmaceuticals Inc | TARS | 0.03% | 90.34K | $5.3M |
| 197 | Trevi Therapeutics Inc | TRVI | 0.03% | 290.05K | $5.3M |
| 198 | Summit Therapeutics Inc | SMMT | 0.02% | 400.17K | $5.2M |
| 199 | Clover Health Investments Corp | CLOV | 0.02% | 1.24M | $5.2M |
| 200 | Establishment Labs Holdings Inc | ESTA | 0.02% | 55.56K | $5.1M |
| 201 | AtaiBeckley Inc | ATAI | 0.02% | 715.89K | $5.1M |
| 202 | CorVel Corp | CRVL | 0.02% | 85.33K | $5.1M |
| 203 | Agios Pharmaceuticals Inc | AGIO | 0.02% | 170.10K | $5.1M |
| 204 | Harmony Biosciences Holdings Inc | HRMY | 0.02% | 144.71K | $5.1M |
| 205 | Newamsterdam Pharma Co NV | NAMS | 0.02% | 183.08K | $5.1M |
| 206 | Biohaven Ltd | BHVN | 0.02% | 376.44K | $5.1M |
| 207 | Enovis Corp | ENOV | 0.02% | 173.99K | $5.1M |
| 208 | Syndax Pharmaceuticals Inc | SNDX | 0.02% | 254.14K | $4.8M |
| 209 | Astrana Health Inc | ASTH | 0.02% | 135.16K | $4.8M |
| 210 | Aurinia Pharmaceuticals Inc | AUPH | 0.02% | 322.51K | $4.8M |
| 211 | Omnicell Inc | OMCL | 0.02% | 134.44K | $4.8M |
| 212 | Nuvation Bio Inc | NUVB | 0.02% | 735.75K | $4.7M |
| 213 | Novocure Ltd | NVCR | 0.02% | 310.59K | $4.6M |
| 214 | UroGen Pharma Ltd | URGN | 0.02% | 117.91K | $4.5M |
| 215 | Sarepta Therapeutics Inc | SRPT | 0.02% | 302.29K | $4.5M |
| 216 | Innoviva Inc | INVA | 0.02% | 213.09K | $4.5M |
| 217 | Viridian Therapeutics Inc | VRDN | 0.02% | 234.49K | $4.4M |
| 218 | Amylyx Pharmaceuticals Inc | AMLX | 0.02% | 217.96K | $4.4M |
| 219 | ANI Pharmaceuticals Inc | ANIP | 0.02% | 55.18K | $4.4M |
| 220 | Nurix Therapeutics Inc | NRIX | 0.02% | 188.29K | $4.4M |
| 221 | Iovance Biotherapeutics Inc | IOVA | 0.02% | 1.06M | $4.3M |
| 222 | Mineralys Therapeutics Inc | MLYS | 0.02% | 168.79K | $4.3M |
| 223 | Recursion Pharmaceuticals Inc | RXRX | 0.02% | 1.43M | $4.3M |
| 224 | MBX Biosciences Inc | MBX | 0.02% | 64.86K | $4.3M |
| 225 | Perrigo Co PLC | PRGO | 0.02% | 418.84K | $4.2M |
| 226 | CONMED Corp | CNMD | 0.02% | 91.37K | $4.2M |
| 227 | Palvella Therapeutics Inc | PVLA | 0.02% | 30.39K | $4.2M |
| 228 | Vera Therapeutics Inc | VERA | 0.02% | 129.87K | $4.2M |
| 229 | Intellia Therapeutics Inc | NTLA | 0.02% | 388.40K | $4.1M |
| 230 | Xeris Biopharma Holdings Inc | XERS | 0.02% | 512.56K | $4.1M |
| 231 | Celcuity Inc | CELC | 0.02% | 47.64K | $4.1M |
| 232 | Pennant Group Inc/The | PNTG | 0.02% | 100.71K | $4.1M |
| 233 | Tandem Diabetes Care Inc | TNDM | 0.02% | 207.72K | $4.1M |
| 234 | Inspire Medical Systems Inc | INSP | 0.02% | 78.60K | $3.9M |
| 235 | AMN Healthcare Services Inc | AMN | 0.02% | 117.15K | $3.9M |
| 236 | GeneDx Holdings Corp | WGS | 0.02% | 59.97K | $3.9M |
| 237 | Kodiak Sciences Inc | KOD | 0.02% | 93.78K | $3.9M |
| 238 | BioLife Solutions Inc | BLFS | 0.02% | 124.33K | $3.9M |
| 239 | Butterfly Network Inc | BFLY | 0.02% | 536.35K | $3.8M |
| 240 | Ocular Therapeutix Inc | OCUL | 0.02% | 462.25K | $3.8M |
| 241 | Harrow Inc | HROW | 0.02% | 95.69K | $3.7M |
| 242 | Precigen Inc | PGEN | 0.02% | 590.35K | $3.7M |
| 243 | Surgery Partners Inc | SGRY | 0.02% | 236.79K | $3.6M |
| 244 | Guardian Pharmacy Services Inc | GRDN | 0.02% | 92.23K | $3.6M |
| 245 | US Physical Therapy Inc | USPH | 0.02% | 46.11K | $3.6M |
| 246 | Teladoc Health Inc | TDOC | 0.02% | 539.19K | $3.6M |
| 247 | Azenta Inc | AZTA | 0.02% | 126.40K | $3.6M |
| 248 | Ardelyx Inc | ARDX | 0.02% | 706.58K | $3.5M |
| 249 | Collegium Pharmaceutical Inc | COLL | 0.02% | 98.26K | $3.5M |
| 250 | MannKind Corp | MNKD | 0.02% | 887.34K | $3.5M |
| 251 | QuidelOrtho Corp | QDEL | 0.02% | 206.23K | $3.5M |
| 252 | Artivion Inc | AORT | 0.02% | 128.65K | $3.5M |
| 253 | Rapport Therapeutics Inc | RAPP | 0.02% | 83.36K | $3.4M |
| 254 | Integra LifeSciences Holdings Corp | IART | 0.02% | 200.41K | $3.3M |
| 255 | Alphatec Holdings Inc | ATEC | 0.02% | 344.21K | $3.3M |
| 256 | Taysha Gene Therapies Inc | TSHA | 0.02% | 556.72K | $3.3M |
| 257 | First Tracks Biotherapeutics Inc | TRAX | 0.02% | 73.79K | $3.2M |
| 258 | Stoke Therapeutics Inc | STOK | 0.02% | 112.12K | $3.2M |
| 259 | Vir Biotechnology Inc | VIR | 0.01% | 355.16K | $3.1M |
| 260 | Novavax Inc | NVAX | 0.01% | 419.78K | $3.1M |
| 261 | Procept Biorobotics Corp | PRCT | 0.01% | 162.46K | $3.0M |
| 262 | Pacira BioSciences Inc | PCRX | 0.01% | 113.60K | $3.0M |
| 263 | HeartFlow Inc | HTFL | 0.01% | 117.12K | $3.0M |
| 264 | Schrodinger Inc/United States | SDGR | 0.01% | 192.09K | $2.9M |
| 265 | agilon health Inc | AGL | 0.01% | 31.46K | $2.9M |
| 266 | Certara Inc | CERT | 0.01% | 350.19K | $2.8M |
| 267 | Xencor Inc | XNCR | 0.01% | 139.20K | $2.8M |
| 268 | AdaptHealth Corp | AHCO | 0.01% | 257.61K | $2.8M |
| 269 | US Dollar | — | 0.01% | 2.71M | $2.7M |
| 270 | EyePoint Inc | EYPT | 0.01% | 215.19K | $2.6M |
| 271 | Personalis Inc | PSNL | 0.01% | 206.23K | $2.6M |
| 272 | AnaptysBio Inc | ANAB | 0.01% | 47.93K | $2.6M |
| 273 | Corvus Pharmaceuticals Inc | CRVS | 0.01% | 191.06K | $2.5M |
| 274 | Zenas Biopharma Inc | ZBIO | 0.01% | 80.41K | $2.5M |
| 275 | Zymeworks Inc | ZYME | 0.01% | 113.97K | $2.5M |
| 276 | Jade Biosciences Inc | JBIO | 0.01% | 125.95K | $2.5M |
| 277 | Omeros Corp | OMER | 0.01% | 207.41K | $2.5M |
| 278 | Bicara Therapeutics Inc | BCAX | 0.01% | 89.41K | $2.4M |
| 279 | MoonLake Immunotherapeutics | MLTX | 0.01% | 131.34K | $2.4M |
| 280 | Monte Rosa Therapeutics Inc | GLUE | 0.01% | 145.59K | $2.4M |
| 281 | iRadimed Corp | IRMD | 0.01% | 25.06K | $2.3M |
| 282 | Castle Biosciences Inc | CSTL | 0.01% | 81.19K | $2.3M |
| 283 | Phibro Animal Health Corp | PAHC | 0.01% | 62.44K | $2.3M |
| 284 | SI-BONE Inc | SIBN | 0.01% | 127.28K | $2.3M |
| 285 | ArriVent Biopharma Inc | AVBP | 0.01% | 73.83K | $2.2M |
| 286 | STAAR Surgical Co | STAA | 0.01% | 90.10K | $2.2M |
| 287 | WaVe Life Sciences Ltd | WVE | 0.01% | 393.92K | $2.2M |
| 288 | Aveanna Healthcare Holdings Inc | AVAH | 0.01% | 230.72K | $2.2M |
| 289 | CryoPort Inc | CYRX | 0.01% | 143.50K | $2.2M |
| 290 | Tyra Biosciences Inc | TYRA | 0.01% | 67.67K | $2.2M |
| 291 | Maravai LifeSciences Holdings Inc | MRVI | 0.01% | 322.04K | $2.1M |
| 292 | Rigel Pharmaceuticals Inc | RIGL | 0.01% | 54.58K | $2.0M |
| 293 | HealthStream Inc | HSTM | 0.01% | 71.13K | $2.0M |
| 294 | Kura Oncology Inc | KURA | 0.01% | 221.20K | $2.0M |
| 295 | MeiraGTx Holdings plc | MGTX | 0.01% | 168.55K | $2.0M |
| 296 | Theravance Biopharma Inc | TBPH | 0.01% | 117.72K | $2.0M |
| 297 | Talkspace Inc | TALK | 0.01% | 379.92K | $2.0M |
| 298 | Aura Biosciences Inc | AURA | 0.01% | 282.54K | $2.0M |
| 299 | Amphastar Pharmaceuticals Inc | AMPH | 0.01% | 97.95K | $2.0M |
| 300 | Sionna Therapeutics Inc | SION | 0.01% | 40.94K | $1.9M |
| 301 | Maze Therapeutics Inc | MAZE | 0.01% | 71.22K | $1.9M |
| 302 | Cullinan Therapeutics Inc | CGEM | 0.01% | 114.81K | $1.9M |
| 303 | Ironwood Pharmaceuticals Inc | IRWD | 0.01% | 447.11K | $1.9M |
| 304 | Tactile Systems Technology Inc | TCMD | 0.01% | 67.13K | $1.9M |
| 305 | Annexon Inc | ANNX | 0.01% | 369.79K | $1.9M |
| 306 | Arbutus Biopharma Corp | ABUS | 0.01% | 433.55K | $1.9M |
| 307 | Janux Therapeutics Inc | JANX | 0.01% | 123.28K | $1.9M |
| 308 | Geron Corp | GERN | 0.01% | 1.45M | $1.9M |
| 309 | Olema Pharmaceuticals Inc | OLMA | 0.01% | 158.61K | $1.8M |
| 310 | Pulse Biosciences Inc | PLSE | 0.01% | 51.57K | $1.8M |
| 311 | Inhibrx Biosciences Inc | INBX | 0.01% | 21.05K | $1.7M |
| 312 | Replimune Group Inc | REPL | 0.01% | 152.05K | $1.7M |
| 313 | Aclaris Therapeutics Inc | ACRS | 0.01% | 326.69K | $1.7M |
| 314 | Sana Biotechnology Inc | SANA | 0.01% | 526.00K | $1.6M |
| 315 | Altimmune Inc | ALT | 0.01% | 573.67K | $1.6M |
| 316 | AngioDynamics Inc | ANGO | 0.01% | 109.66K | $1.6M |
| 317 | Kestra Medical Technologies Ltd | KMTS | 0.01% | 70.83K | $1.6M |
| 318 | Mesa Laboratories Inc | MLAB | 0.01% | 15.91K | $1.6M |
| 319 | Tilray Brands Inc | TLRY | 0.01% | 351.39K | $1.6M |
| 320 | Bioventus Inc | BVS | 0.01% | 120.94K | $1.6M |
| 321 | CorMedix Inc | CRMD | 0.01% | 209.71K | $1.6M |
| 322 | Savara Inc | SVRA | 0.01% | 279.99K | $1.5M |
| 323 | OPKO Health Inc | OPK | 0.01% | 1.15M | $1.5M |
| 324 | CytomX Therapeutics Inc | CTMX | 0.01% | 487.92K | $1.5M |
| 325 | Phreesia Inc | PHR | 0.01% | 139.26K | $1.5M |
| 326 | Lexicon Pharmaceuticals Inc | LXRX | 0.01% | 642.48K | $1.5M |
| 327 | MiMedx Group Inc | MDXG | 0.01% | 356.92K | $1.5M |
| 328 | Allogene Therapeutics Inc | ALLO | 0.01% | 782.87K | $1.5M |
| 329 | Varex Imaging Corp | VREX | 0.01% | 128.04K | $1.4M |
| 330 | ORIC Pharmaceuticals Inc | ORIC | 0.01% | 128.53K | $1.4M |
| 331 | Cytek Biosciences Inc | CTKB | 0.01% | 328.15K | $1.4M |
| 332 | Solid Biosciences Inc | SLDB | 0.01% | 164.29K | $1.3M |
| 333 | Arvinas Inc | ARVN | 0.01% | 164.61K | $1.3M |
| 334 | Relmada Therapeutics Inc | RLMD | 0.01% | 246.45K | $1.3M |
| 335 | Phathom Pharmaceuticals Inc | PHAT | 0.01% | 149.37K | $1.3M |
| 336 | Vor BioPharma Inc | VOR | 0.01% | 61.60K | $1.3M |
| 337 | REGENXBIO Inc | RGNX | 0.01% | 132.96K | $1.3M |
| 338 | Ocugen Inc | OCGN | 0.01% | 994.78K | $1.2M |
| 339 | Editas Medicine Inc | EDIT | 0.01% | 465.53K | $1.2M |
| 340 | Cerus Corp | CERS | 0.01% | 553.56K | $1.2M |
| 341 | Ceribell Inc | CBLL | 0.01% | 65.65K | $1.2M |
| 342 | Sutro Biopharma Inc | STRO | 0.01% | 47.72K | $1.2M |
| 343 | Omada Health Inc | OMDA | 0.01% | 58.07K | $1.2M |
| 344 | Orthofix Medical Inc | OFIX | 0.01% | 97.36K | $1.1M |
| 345 | 4D Molecular Therapeutics Inc | FDMT | 0.01% | 108.50K | $1.1M |
| 346 | Emergent BioSolutions Inc | EBS | 0.01% | 152.77K | $1.1M |
| 347 | Shattuck Labs Inc | STTK | 0.01% | 154.72K | $1.1M |
| 348 | OrthoPediatrics Corp | KIDS | 0.01% | 52.73K | $1.1M |
| 349 | Prothena Corp PLC | PRTA | 0.01% | 130.90K | $1.1M |
| 350 | Neurogene Inc | NGNE | 0.00% | 31.40K | $1.0M |
| 351 | Septerna Inc | SEPN | 0.00% | 29.98K | $1.0M |
| 352 | Pacific Biosciences of California Inc | PACB | 0.00% | 732.69K | $1.0M |
| 353 | Akebia Therapeutics Inc | AKBA | 0.00% | 760.32K | $1.0M |
| 354 | Community Health Systems Inc | CYH | 0.00% | 352.58K | $983.7K |
| 355 | Starling Oncology Inc | STLN | 0.00% | 202.31K | $983.2K |
| 356 | Simulations Plus Inc | SLP | 0.00% | 52.43K | $955.7K |
| 357 | Fulgent Genetics Inc | FLGT | 0.00% | 56.97K | $942.9K |
| 358 | Verastem Inc | VSTM | 0.00% | 160.08K | $928.5K |
| 359 | Prime Medicine Inc | PRME | 0.00% | 315.05K | $919.9K |
| 360 | Ginkgo Bioworks Holdings Inc | DNA | 0.00% | 113.60K | $919.0K |
| 361 | Crescent Biopharma Inc | CBIO | 0.00% | 62.24K | $900.6K |
| 362 | Rezolute Inc | RZLT | 0.00% | 188.96K | $891.9K |
| 363 | Evolent Health Inc | EVH | 0.00% | 285.40K | $881.9K |
| 364 | GoodRx Holdings Inc | GDRX | 0.00% | 281.37K | $863.8K |
| 365 | Rocket Pharmaceuticals Inc | RCKT | 0.00% | 261.94K | $814.6K |
| 366 | Perspective Therapeutics Inc | CATX | 0.00% | 279.58K | $813.6K |
| 367 | Vanda Pharmaceuticals Inc | VNDA | 0.00% | 157.06K | $801.0K |
| 368 | Evolus Inc | EOLS | 0.00% | 136.80K | $798.9K |
| 369 | Myriad Genetics Inc | MYGN | 0.00% | 276.30K | $790.2K |
| 370 | Lumexa Imaging Holdings Inc | LMRI | 0.00% | 72.87K | $758.5K |
| 371 | OraSure Technologies Inc | OSUR | 0.00% | 185.27K | $750.4K |
| 372 | Anavex Life Sciences Corp | AVXL | 0.00% | 269.22K | $740.4K |
| 373 | ARS Pharmaceuticals Inc | SPRY | 0.00% | 143.23K | $734.8K |
| 374 | Atea Pharmaceuticals Inc | AVIR | 0.00% | 155.53K | $731.0K |
| 375 | Zentalis Pharmaceuticals Inc | ZNTL | 0.00% | 152.30K | $721.9K |
| 376 | Tectonic Therapeutic Inc | TECX | 0.00% | 25.64K | $718.5K |
| 377 | RxSight Inc | RXST | 0.00% | 118.95K | $714.9K |
| 378 | Fate Therapeutics Inc | FATE | 0.00% | 283.03K | $693.4K |
| 379 | Larimar Therapeutics Inc | LRMR | 0.00% | 173.45K | $662.6K |
| 380 | Treace Medical Concepts Inc | TMCI | 0.00% | 152.28K | $656.3K |
| 381 | Assembly Biosciences Inc | ASMB | 0.00% | 25.26K | $634.3K |
| 382 | Embecta Corp | EMBC | 0.00% | 170.88K | $622.0K |
| 383 | Standard BioTools Inc | LAB | 0.00% | 679.93K | $590.2K |
| 384 | Accendra Health Inc | ACH | 0.00% | 186.31K | $575.7K |
| 385 | Capricor Therapeutics Inc | CAPR | 0.00% | 140.27K | $540.0K |
| 386 | Fulcrum Therapeutics Inc | FULC | 0.00% | 141.49K | $506.5K |
| 387 | Keros Therapeutics Inc | KROS | 0.00% | 49.65K | $499.9K |
| 388 | Compass Therapeutics Inc | CMPX | 0.00% | 259.83K | $496.3K |
| 389 | OmniAb Inc | OABI | 0.00% | 240.88K | $476.9K |
| 390 | Upstream Bio Inc | UPB | 0.00% | 73.31K | $462.6K |
| 391 | Organogenesis Holdings Inc | ORGO | 0.00% | 191.24K | $453.2K |
| 392 | Arcturus Therapeutics Holdings Inc | ARCT | 0.00% | 75.88K | $437.1K |
| 393 | Quanterix Corp | QTRX | 0.00% | 118.36K | $411.9K |
| 394 | SIGA Technologies Inc | SIGA | 0.00% | 120.13K | $392.8K |
| 395 | Entrada Therapeutics Inc | TRDA | 0.00% | 57.77K | $392.2K |
| 396 | Century Therapeutics Inc | IPSC | 0.00% | 191.11K | $386.0K |
| 397 | Humacyte Inc | HUMA | 0.00% | 572.90K | $374.3K |
| 398 | Evommune Inc | EVMN | 0.00% | 32.79K | $368.9K |
| 399 | Lyell Immunopharma Inc | LYEL | 0.00% | 28.37K | $367.1K |
| 400 | Quantum-Si Inc | QSI | 0.00% | 500.97K | $356.9K |
| 401 | Alector Inc | ALEC | 0.00% | 231.78K | $350.0K |
| 402 | Claritev Corp | CTEV | 0.00% | 15.21K | $345.5K |
| 403 | MapLight Therapeutics Inc | MPLT | 0.00% | 25.12K | $327.0K |
| 404 | Neumora Therapeutics Inc | NMRA | 0.00% | 197.63K | $318.2K |
| 405 | LENZ Therapeutics Inc | LENZ | 0.00% | 57.23K | $303.3K |
| 406 | MaxCyte Inc | MXCT | 0.00% | 282.93K | $297.1K |
| 407 | Korro Bio Inc | KRRO | 0.00% | 28.48K | $295.3K |
| 408 | Health Catalyst Inc | HCAT | 0.00% | 136.80K | $285.9K |
| 409 | Aldeyra Therapeutics Inc | ALDX | 0.00% | 166.76K | $256.8K |
| 410 | Heron Therapeutics Inc | HRTX | 0.00% | 475.80K | $236.1K |
| 411 | DocGo Inc | DCGO | 0.00% | 262.30K | $170.7K |
| 412 | Pliant Therapeutics Inc | PLRX | 0.00% | 154.87K | $161.1K |
| 413 | Filana Therapeutics Inc | FLNA | 0.00% | 133.60K | $134.9K |
| 414 | Gossamer Bio Inc | GOSS | 0.00% | 548.97K | $93.1K |
| 415 | Definitive Healthcare Corp | DH | 0.00% | 55.22K | $37.7K |
| 416 | HOLOGIC INC - CVR (APRIL 2026) | HO1.DE | 0.00% | 162.94K | $1.6K |
| 417 | ROCHE HOLDING AG - CVR (OCT 2025) | RHHBF | 0.00% | 240 | $81.60 |
| 418 | PREVAIL THERAPEU - CVR | — | 0.00% | 78 | $39.00 |
| 419 | OMNIAB INC - 12.5 EARNOUT | — | 0.00% | 22.08K | $0.22 |
| 420 | OMNIAB INC - 15 EARNOUT | — | 0.00% | 22.08K | $0.22 |
| 421 | CHINOOK THERAPEUTICS INC - CVR (AUG 2023) | KDNY | 0.00% | 784 | $0.00 |
Klik op een ticker om alle ETF's te zien die dit aandeel bevatten.
Sectorblootstelling
Geografische blootstelling
Landgewichten zoals gerapporteerd door de dataprovider. De labels ontwikkeld/opkomend/frontier volgen de classificatie op de Methodologiepagina. Valuta-afgedekt: Geen hedging aangegeven in de fondsnaam.
Distributies
| Yield (TTM) | 1.45% | Uitgekeerd (afgelopen 12 maanden) | $4.7227 |
| Frequentie | Quarterly | SEC-rendement | Niet verstrekt door onze databron — zie de uitgeverpagina |
| Laatste ex-datum | Jun 24, 2026 | Laatste betaling | $0.9868 (Jun 26, 2026) |
| Groei 1J | +18.45% | Groei 3J / 5J (gem. jaarl.) | +11.17% / +10.65% |
| Ex-datum | Registratiedatum | Uitkeringsdatum | Bedrag |
|---|---|---|---|
| Jun 24, 2026 | Jun 24, 2026 | Jun 26, 2026 | $0.9868 |
| Mar 24, 2026 | Mar 24, 2026 | Mar 26, 2026 | $0.9940 |
| Dec 17, 2025 | Dec 17, 2025 | Dec 19, 2025 | $1.6654 |
| Sep 24, 2025 | Sep 24, 2025 | Sep 26, 2025 | $1.0765 |
| Jun 26, 2025 | Jun 26, 2025 | Jun 30, 2025 | $0.9619 |
| Mar 25, 2025 | Mar 25, 2025 | Mar 27, 2025 | $0.9396 |
| Dec 18, 2024 | Dec 18, 2024 | Dec 20, 2024 | $0.9188 |
| Sep 27, 2024 | Sep 27, 2024 | Oct 01, 2024 | $1.1666 |
| Jun 28, 2024 | Jun 28, 2024 | Jul 02, 2024 | $0.9656 |
| Mar 22, 2024 | Mar 25, 2024 | Mar 27, 2024 | $0.8189 |
| Dec 19, 2023 | Dec 20, 2023 | Dec 22, 2023 | $0.8947 |
| Sep 28, 2023 | Sep 29, 2023 | Oct 03, 2023 | $0.8774 |
Volgend distributierendement = laatste 12 maanden aan uitkeringen ÷ huidige prijs. Dit is NIET het SEC 30-daags rendement en uitkeringen zijn niet gegarandeerd. Het verschil uitgelegd →
Risicostatistieken
| Volatiliteit 1J / 3J | 15.38% / 14.62% | Sharpe 1J / 3J | 1.85 / 0.643 |
| Max. drawdown 1J / 3J | -10.40% / -16.91% | Sortino 1J | 3.18 |
| Beta t.o.v. S&P 500 (3J) | 0.503 | Correlatie t.o.v. S&P 500 (1J) | 0.29 |
| Neerwaartse deviatie 1J | 8.96% | Gebruikte risicovrije rente | 3.71% (3M T-bill, FRED) |
Berekend door ETF Explorer op basis van dagelijkse dividendgecorrigeerde slotkoersen; volatiliteit en drawdown zijn geannualiseerde/periodecijfers; S&P 500-blootstelling bij benadering via SPY. Per Aug 27, 2026. Formules →
Liquiditeit
| Volume vandaag | 279.58K | Gemiddeld volume | 238.32K |
| AUM | $20.90B | Premie/korting | +0.04% |
| Bied/laat-spread | Niet verstrekt door onze databron. Raadpleeg het koersscherm van uw broker; spreads zijn het grootst bij opening en sluiting. | ||
Premium/korting vergelijkt de vertraagde marktprijs met de laatst gerapporteerde NAV — een indicatieve waarde, niet de officiële slotpremium/korting. Hoe ETF-liquiditeit werkt →
Fondsstromen (geschat)
| Periode | Geschatte netto-geldstroom | % van het begin-AUM | AUM begin → eind |
|---|---|---|---|
| 1 dag | $0.00 | 0.00% | $20.90B → $20.90B |
| 1 week | -$166.6M | -0.80% | $20.90B → $20.90B |
ETF Explorer-schatting: verandering in gerapporteerd vermogen (AUM) minus het markbewegingseffect, op basis van onze eigen dagelijkse momentopnames. Geen officiële creatie-/terugkoopgegevens van de uitgevende instelling.
Officiële fondsbronnen
Officiële fondspagina ↗
Website ETF-uitgever (Vanguard) ↗
Prospectusregistraties (SEC EDGAR) ↗
Jaar- / halfjaarverslagen (SEC EDGAR) ↗
Alle SEC-ingediende stukken ↗
Externe links openen de website van de uitgever of SEC EDGAR in een nieuw tabblad. Het prospectus en de officiële documenten zijn altijd de gezaghebbende bron — raadpleeg deze voordat u belegt.
Laatste nieuws over VHT
Geen artikelen vermelden dit fonds direct in de afgelopen 7 dagen — algemene ETF-berichtgeving wordt getoond.
More Sudanese oil available for marine fuel blending as China demand eases ↗
More barrels of South Sudan's Dar Blend crude oil returned to the marine fuel blending pool in Singapore and Malaysia this month as demand from…
Reuters · Aug 27, 01:30 UTC
Gold (XAU/USD) & Silver Price Forecast: Sticky PCE Puts Warsh and Fed in Focus ↗
Gold and silver remain balanced as sticky PCE revives Fed tightening risk, while Warsh, Middle East tensions and fiscal concerns support volatility.
FXEmpire · Aug 27, 01:14 UTC
Natural Gas and Oil Forecast: Diesel Stocks Tighten as Hormuz Flows Slowly Recover ↗
Hormuz talks ease some oil supply fears, but tight diesel stocks keep fuel markets constrained as WTI and Brent remain technically vulnerable.
FXEmpire · Aug 27, 01:09 UTC
Kospi Index on edge as SK Hynix stock jumps after strong Nvidia guidance ↗
The Kospi Index wavered on Thursday after the Bank of Korea (BoK) delivered a second interest rates hike as it battles with the relatively elevated…
Invezz · Aug 27, 00:22 UTC
Gold Rises as Dollar Debasement Trade Attracts Investors ↗
Gold rose in Asian trade. The precious metal faces limited downside due to the so-called dollar debasement trade continuing to attract investor…
WSJ · Aug 26, 23:45 UTC
BOJ Deputy Gov. Himino Vows Inflation Vigilance as Rate-Hike Bets Mount ↗
The overnight index swaps market is pricing in nearly a 90% chance of a rate increase at the upcoming Bank of Japan meeting.
WSJ · Aug 26, 22:46 UTC
Al het nieuws voor VHT →
Begeleide uitleg: AUM is de fondsomvang. De expense ratio is de jaarlijkse kostenvergoeding die in het rendement is verwerkt. NAV is de waarde van wat het fonds per aandeel bezit; de marktprijs kan daar iets boven (premie) of onder (korting) liggen. Totaalrendement gaat ervan uit dat uitkeringen zijn herbelegd. Elke dataset toont zijn eigen peildatum, omdat posities, vermogen en koersen op verschillende momenten worden bijgewerkt.